Skip to main content
OpenTrials
Completed

NCT Number: NCT04841083

Narrow Band Green Light and Migraine

Study volunteers are asked to use the Allay Lamp routinely during the 6-week study period. A web based survey is provided when the Lamp is purchased for study volunteers to complete. A daily usage paper diary is sent with the lamp so that volunteers can keep track of the frequency and duration of lamp usage and any noticeable benefits. At the end of six weeks a second survey is sent to study volunteers to capture their perceptions of potential lamp benefits with respect to headache frequency and their experience of migraine specific symptoms.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Migraine Brain Diseases Central Nervous System Diseases Headache Headache Disorders Headache Disorders, Primary Migraine Disorders Nervous System Diseases Neurologic Manifestations Pain Pathological Conditions, Signs and Symptoms Signs and Symptoms

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Vendata Research

Chapel Hill, North Carolina, 27517, United States

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Adults with headaches or migraines.

Exclusion criteria

  • Not having headaches or migraines

Treatment and study plan

Allay Lamp

Device

The Allay Lamp is a consumer product currently available and widely used in the US. It emits low intensity (1-10 lux) narrow band (20 nm) green light (peak wavelength 520 nm) that is marketed as non-irritating to users. In that context, it is not a medical device and does not require a 510(k).

Primary outcomes

  1. Change in number of headache days per week

    Time frame: Change from baseline at 6 weeks

    Number of days with headache per week without and with using the Allay lamp

  2. Change in number of headache days per month

    Time frame: Changes from baseline at weeks 3-6 of using the Allay lamp

    Number of days with headache per month without and with using the Allay lamp

  3. Change in frequency of experiencing photophobia

    Time frame: Changes from baseline at 6 weeks of using the Allay Lamp.

    Assessing frequency of photophobia during days with headache as depicted by participants using the following options: (1)never, rarely, (2)less than half, (3)half or more, (4)nearly all the time.

  4. Change in headache severity

    Time frame: Changes from baseline at 6 weeks of using the Allay lamp

    Assessing headache severity while using the Allay lamp. Improvement is determined by the number of times participants answer Yes or NO in their daily diary.

Sponsors and collaborators

Lead sponsor

Vedanta Research

Other

Registry information

Official study title

A Real World Evaluation of the Allay Lamp in Reducing Headache Symptoms and Frequency

Important dates

Study start
2020
Primary completion
2022
Study completion
2022
First posted
Apr 12, 2021
Registry last updated
Dec 8, 2022

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.